Other content tagged: drug development
Canada’s Rare Disease Strategy – 5th Anniversary
Interview with Durhane Wong-Rieger, PhD, President & CEO, Canadian Organization for Rare Disorders and Chair, Rare Disease International Dr Wong-Rieger, what was the idea behind your strategy and what was the starting point? Before we, as the Canadian Organization for Rare Disorders, could bring people together to consider a national “rare disease strategy”, we had to answer the question, “what do rare diseases have in common?” What could we possibly offer patients…
Read more